Treatment resistance and relapse in the most common type of lung cancer can be traced to a protein called agrin, according to ...

Electronic "nose" analysis of exhaled breath achieved 80-90% accuracy for detecting lung cancer in patients with suspicious ...

A new medication is helping doctors identify tumors during lung cancer surgery. Cytalux, an FDA-approved dye, is administered ...

Dame Esther Rantzen has issued a candid update on her health, following her diagnosis with stage four lung cancer two years ...

A lung cancer diagnosis was a true shock for one man. He didn't believe he was at risk. Now, he's taking his story and ...

Researchers from Touro University and Lovelace Biomedical are Developing an Innovative Treatment for Lung Cancer ...

Lung cancer screening has the potential to catch lung cancer early and save lives—but only if people get screened. Although ...

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

Feb. 6, 2025 — Scientists have created a new low-cost, fast response sensor to detect lung cancer biomarkers, paving the way for the development of screening devices to spot the disease even ...

A study finds only 18% of eligible smokers get lung cancer screenings despite the test being quick and simple. Experts urge ...

This week Bobbi Conner talks with Dr. Miriam Alexander about advances in lung cancer treatment in recent years. Dr. Alexander ...

Eighty-five percent of diagnosed cases of lung cancer are non-small cell lung cancer (NSCLC). In this group, 5% of patients show molecular alterations in the ALK gene involved in cell multiplication.